Replies to post #118900 on Biotech Values

[DewDiligence]

REGN/SNY—Zaltrap phase-3 trial in CRPC will continue to final analysis:

http://finance.yahoo.com/news/Phase-3-Trial-of-ZALTRAP-prnews-3730434900.html?x=0&.v=1

This trial, called VENICE, is testing Taxotere ± Zaltrpa in first-line CRPC.